Skip to main content
. Author manuscript; available in PMC: 2019 Dec 5.
Published in final edited form as: Drug Dev Res. 1999 Mar 1;45(3-4):113–124. doi: 10.1002/(SICI)1098-2299(199811/12)45:3/4<113::AID-DDR5>3.0.CO;2-S

Fig. 2.

Fig. 2.

Structures of highly potent A3 adenosine receptor agonists. Ki values in receptor binding at rat (unless indicated) A1/A2A/A3 receptors (nM) are shown. h, human.